Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program

The United States continues to experience an opioid epidemic of unprecedented proportions despite FDA approval of life saving medications, such as buprenorphine. This paper describes a novel group-based buprenorphine treatment model and summarizes patient characteristics and treatment retention. This model, known as the Comprehensive Opioid Addiction Treatment (COAT) program, was developed in West Virginia, the epicenter of the opioid epidemic.

https://www.jns-journal.com/article/S0022-510X(20)30048-4/fulltext?rss=yes

Source: Journal of the Neurological Sciences - February 2, 2020 Category: Neurology Authors: Laura R. Lander, Wanhong Zheng, Jeremy D. Hustead, James J. Mahoney, James H. Berry, Patrick Marshalek, Erin L. Winstanley Tags: Review Article Source Type: research